In addition, analysis utilizing the GEPIA database uncovered higher expression levels of ARSK, CYP27A1, FAM120B, MECR, and RAN in DLBCL patients in comparison to normal controls (Fig. 6D). Here, RAN is linked to diffuse large B-cell lymphoma.